Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
Royal Marsden NHS Foundation Trust
Royal Marsden NHS Foundation Trust
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Royal Marsden NHS Foundation Trust
University of Iowa
National Cancer Institute (NCI)
Institut Bergonié
Eli Lilly and Company
Eli Lilly and Company
National Taiwan University Hospital
ImmunoGenesis
Hutchmed
Columbia University
Intensity Therapeutics, Inc.
Cogent Biosciences, Inc.
Oncternal Therapeutics, Inc
BeiGene
NantCell, Inc.
Fred Hutchinson Cancer Center
Children's Oncology Group
University of Iowa
Hutchmed
Theseus Pharmaceuticals
Lumos Pharma
Cellestia Biotech AG
Bayer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Y-mAbs Therapeutics
Eli Lilly and Company
Eisai Inc.
Eisai Inc.
M.D. Anderson Cancer Center
Rush University Medical Center
Bristol-Myers Squibb
Nektar Therapeutics
Atara Biotherapeutics
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
National Cancer Institute (NCI)
Eisai Inc.
Radiation Therapy Oncology Group
Celgene
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)